Ayurvedic practitioners and researchers in India and the US are planning to initiate joint clinical trials for ayurveda formulations against the novel coronavirus, the Indian envoy here has said.
In a virtual interaction with a group of eminent Indian-American scientists, academics and doctors on Wednesday, Indian Ambassador to US Taranjit Singh Sandhu said the vast network of institutional engagements had brought scientific communities between the two countries together in the fight against Covid-19.
“Our institutions have also been collaborating to promote ayurveda through joint research, teaching and training programs. Ayurvedic practitioners and researchers in both the countries are planning to initiate joint clinical trials of ayurvedic formulations against Covid-19,” Sandhu said.
Our scientists have been exchanging knowledge and research resources on this front,” he said.
The Indo-US Science Technology Forum (IUSSTF) has always been instrumental in promoting excellence in science, technology and innovation through collaborative activities.
To address Covid-19-related challenges, the IUSSTF had given a call to support joint research and start-up engagements. A large number of proposals are being reviewed on fast-track mode by the experts on both the sides, he said.
“Indian pharmaceutical companies are global leaders in producing affordable low-cost medicines and vaccines and will play an important role in the fight against this pandemic,” Sandhu said.
According to the ambassador, there are at least three ongoing collaborations between Indian vaccine companies with US-based institutions.
These collaborations would be beneficial not just to India and the US, but also for the billions who would need to be vaccinated against Covid-19 across the world, he noted.
